Vanguard Group
BTTX

Vanguard Group’s Better Therapeutics, Inc. Common Stock BTTX Stock Holding History

Vanguard Group’s Portfolio BTTX Stock Details BTTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
2023
Q4 		$38.6K Sell
2023
Q3 		$183K Buy
2023
Q2 		$474K Hold
2023
Q1 		$307K Buy
2022
Q4 		$480K Buy
2022
Q3 		$765K Buy
2022
Q2 		$520K Buy
2022
Q1 		$563K Buy
2021
Q4 		$947K Buy